Archives

by in
Entry Author Date Location
Cancer Immunotherapy Companies: Looking Forward and Looking Back 03/02/15 Seattle
End of Dendreon: Valeant’s $400M is Sole Offer, Purchase is Next 02/10/15 Seattle
More Biotechs Belly-Up These Days but Dendreon Still “One of a Kind” 12/02/14 National
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
As Huge Bills Loom, Immunotherapy Pioneer Dendreon Enters Bankruptcy 11/10/14 Seattle
Former Dendreon CEO Gold Working on New Cancer Drug Startups 10/13/14 Wisconsin
Madison Startup Rides Immunotherapy Wave With Prostate Drug 08/18/14 Wisconsin
West Coast Biotech Roundup: Onyx, Calico, Otonomy, Dendreon & More 08/14/14 San Francisco
Dendreon Cuts 150 Jobs, As Prostate Cancer Drug Sales Decline 11/12/13 Seattle
Report: Dendreon Looking to Get Acquired 10/26/13 Seattle
Dendreon Says Sales Will Decline in 2013, Shares Fall 08/08/13 Seattle
Genentech Follows Fast at ASCO as Cancer Immunotherapy Picks Up 05/15/13 San Francisco
Dendreon Shares Fall Again, as Provenge Sales Slump 05/09/13 Seattle
Medivation Wins FDA Approval of Prostate Cancer Drug 08/31/12 San Francisco
Richard Brewer, Former Scios CEO and Dendreon Chairman, Dies at 61 08/15/12 San Francisco
OncoGenex Waits, and Waits, For Data on Prostate Cancer Drug 08/02/12 Seattle
Dendreon Cutting 600 Jobs, Closing NJ Plant As Sales Fall Short 07/30/12 Seattle
Dendreon Shareholders Vent at Annual Meeting 06/13/12 Seattle
Emerging Challenges of Prostate Cancer Drug Development 06/06/12 National
Medivation Emerges With New Prostate Cancer Drug 05/31/12 San Francisco
Dendreon’s Provenge Works Best for Patients With Low PSA, Scientists Say 05/16/12 Seattle
NY’s Cancer Research Institute Looks to Boost Cancer Immunotherapy 05/09/12 New York
Dendreon Meets Expectations with $82M in 1st Quarter Provenge Sales 05/07/12 Seattle
Analyst: Dendreon’s Growth Stalling With Cancer Docs as Rival Gains 05/04/12 Seattle
Dendreon CEO John Johnson: ‘This is My Last Stop’ 04/17/12 Seattle
J&J Prostate Cancer Drug Hits Goal; Hurts Dendreon, Helps Medivation 03/08/12 New York
Dendreon Adds ImClone Vets to New Management Team 02/28/12 Seattle
Dendreon Stock Tumbles As Company Projects ‘Moderate’ Sales Growth 02/27/12 Seattle
Dendreon Names John Johnson CEO After Volatile Year 02/01/12 Seattle
Dendreon Surprises With $82M in Fourth Quarter Sales, Stock Booms 01/05/12 Seattle
Page 1 of 6 next page »